ClinConnect ClinConnect Logo
Search / Trial NCT07061600

Enhancing Depression Literacy and Reducing Stigma in Adolescents Through Social Media

Launched by LUDWIG-MAXIMILIANS - UNIVERSITY OF MUNICH · Jul 10, 2025

Trial Information

Current as of July 23, 2025

Recruiting

Keywords

Depression Social Media Adolescents Depression Literacy Stigma Help Seeking Psychoeducation Ecological Momentary Assessment

ClinConnect Summary

This study is looking at whether using an Instagram channel called "ich bin alles" ("I am everything") can help teenagers learn more about depression, reduce negative feelings or stigma around it, and encourage them to seek help if they need it. Depression is common among young people but often goes unrecognized or untreated because many don’t know enough about it or are afraid of being judged. Since teens spend a lot of time on social media, this project shares easy-to-understand and trustworthy information about depression and mental health through digital platforms like Instagram.

To join the study, participants need to be regular Instagram users and have their own Instagram account. The study is open to people of all genders within the age range of 47 to 74 years old. Participants will engage with the Instagram content and the researchers will look at how well the channel helps improve understanding of depression, lowers stigma, and influences whether people are more willing to seek help. The study is currently recruiting participants, and there are no other restrictions for joining.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Ownership of an Instagram account
  • Regular use of Instagram
  • Exclusion Criteria:
  • No exclusion citeria

About Ludwig Maximilians University Of Munich

Ludwig-Maximilians-University of Munich (LMU Munich) is a prestigious research institution in Germany, renowned for its commitment to advancing medical science and improving patient care through innovative clinical research. As a leading sponsor of clinical trials, LMU Munich leverages its extensive academic resources and interdisciplinary expertise to conduct rigorous studies aimed at evaluating new therapeutic interventions and advancing healthcare knowledge. The university fosters collaboration among researchers, clinicians, and healthcare professionals, ensuring that trials are designed and executed with the highest ethical standards and scientific integrity. Through its dedication to excellence in research, LMU Munich aims to contribute significantly to the development of effective treatments and enhance the overall health outcomes for diverse patient populations.

Locations

Munich, Bavaria, Germany

Patients applied

0 patients applied

Trial Officials

Gerd Schulte-Körne, Prof. Dr.

Principal Investigator

Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, Hospital of the Ludwig-Maximilians-University (LMU) Munich

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported